Patents by Inventor Michael Saul

Michael Saul has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260207584
    Abstract: Provided herein are methods and compositions for the treatment or prevention of certain disorders and conditions, for example, addiction using an agent to modulate 5-hydroxytryptamine 1D receptor (HTR1D) activity and/or expression. Also provided are methods for screening a candidate to determine if the candidate is suitable for the therapies disclosed herein.
    Type: Application
    Filed: January 21, 2026
    Publication date: July 23, 2026
    Applicant: The Jackson Laboratory
    Inventors: Elissa Chesler, Michael Saul
  • Patent number: 12551481
    Abstract: Provided herein are methods and compositions for the treatment or prevention of certain disorders and conditions, for example, addiction using an agent to modulate 5-hydroxytryptamine 1D receptor (HTR1D) activity and/or expression. Also provided are methods for screening a candidate to determine if the candidate is suitable for the therapies disclosed herein.
    Type: Grant
    Filed: December 18, 2020
    Date of Patent: February 17, 2026
    Assignee: The Jackson Laboratory
    Inventors: Elissa Chesler, Michael Saul
  • Publication number: 20230057844
    Abstract: Provided herein are methods and compositions for the treatment or prevention of certain disorders and conditions, for example, addiction using an agent to modulate 5-hydroxytryptamine 1D receptor (HTR1D) activity and/or expression. Also provided are methods for screening a candidate to determine if the candidate is suitable for the therapies disclosed herein.
    Type: Application
    Filed: December 18, 2020
    Publication date: February 23, 2023
    Applicant: The Jackson Laboratory
    Inventors: Elissa Chesler, Michael Saul